241 related articles for article (PubMed ID: 26418879)
1. TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells.
Liu X; Liao W; Yuan Q; Ou Y; Huang J
Oncotarget; 2015 Oct; 6(33):34309-20. PubMed ID: 26418879
[TBL] [Abstract][Full Text] [Related]
2. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling.
Xie B; Zen Q; Wang X; He X; Xie Y; Zhang Z; Li H
Int J Oncol; 2015 May; 46(5):2057-66. PubMed ID: 25738261
[TBL] [Abstract][Full Text] [Related]
3. Expression and function analysis of mitotic checkpoint genes identifies TTK as a potential therapeutic target for human hepatocellular carcinoma.
Liang XD; Dai YC; Li ZY; Gan MF; Zhang SR; Yin-Pan ; Lu HS; Cao XQ; Zheng BJ; Bao LF; Wang DD; Zhang LM; Ma SL
PLoS One; 2014; 9(6):e97739. PubMed ID: 24905462
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
5. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of ACK1 can inhibit the proliferation of hepatocellular carcinoma cells through the PTEN/AKT/mTOR pathway.
Wang B; Song K; Chen L; Su H; Gao L; Liu J; Huang A
Cell Biochem Funct; 2020 Jul; 38(5):642-650. PubMed ID: 32162707
[TBL] [Abstract][Full Text] [Related]
7. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
[TBL] [Abstract][Full Text] [Related]
8. Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt pathway.
Zhang L; Jiang B; Zhu N; Tao M; Jun Y; Chen X; Wang Q; Luo C
Med Oncol; 2019 Nov; 37(1):5. PubMed ID: 31720873
[TBL] [Abstract][Full Text] [Related]
9. TTK regulates proliferation and apoptosis of gastric cancer cells through the Akt-mTOR pathway.
Huang H; Yang Y; Zhang W; Liu X; Yang G
FEBS Open Bio; 2020 Aug; 10(8):1542-1549. PubMed ID: 32530571
[TBL] [Abstract][Full Text] [Related]
10. Utility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancer.
Miao R; Wu Y; Zhang H; Zhou H; Sun X; Csizmadia E; He L; Zhao Y; Jiang C; Miksad RA; Ghaziani T; Robson SC; Zhao H
Sci Rep; 2016 Sep; 6():33121. PubMed ID: 27618777
[TBL] [Abstract][Full Text] [Related]
11. A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer.
Chen X; Yu C; Gao J; Zhu H; Cui B; Zhang T; Zhou Y; Liu Q; He H; Xiao R; Huang R; Xie H; Gao D; Zhou H
Theranostics; 2018; 8(9):2348-2360. PubMed ID: 29721084
[TBL] [Abstract][Full Text] [Related]
12. Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways.
Zhao B; Zhao W; Wang Y; Xu Y; Xu J; Tang K; Zhang S; Yin Z; Wu Q; Wang X
Oncotarget; 2015 Apr; 6(12):10116-33. PubMed ID: 25426556
[TBL] [Abstract][Full Text] [Related]
13. TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.
Maire V; Baldeyron C; Richardson M; Tesson B; Vincent-Salomon A; Gravier E; Marty-Prouvost B; De Koning L; Rigaill G; Dumont A; Gentien D; Barillot E; Roman-Roman S; Depil S; Cruzalegui F; Pierré A; Tucker GC; Dubois T
PLoS One; 2013; 8(5):e63712. PubMed ID: 23700430
[TBL] [Abstract][Full Text] [Related]
14. Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells.
Kaistha BP; Honstein T; Müller V; Bielak S; Sauer M; Kreider R; Fassan M; Scarpa A; Schmees C; Volkmer H; Gress TM; Buchholz M
Br J Cancer; 2014 Oct; 111(9):1780-7. PubMed ID: 25137017
[TBL] [Abstract][Full Text] [Related]
15. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
[TBL] [Abstract][Full Text] [Related]
16. TTK inhibitor promotes radiosensitivity of liver cancer cells through p21.
Zhang H; Yao W; Zhang M; Lu Y; Tang J; Jiang M; Mou X; You G; Liang X
Biochem Biophys Res Commun; 2021 Apr; 550():84-91. PubMed ID: 33689884
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling.
Lee EK; Kim HJ; Lee KJ; Lee HJ; Lee JS; Kim DG; Hong SW; Yoon Y; Kim JS
Int J Oncol; 2011 Feb; 38(2):325-33. PubMed ID: 21132267
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
19. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
[TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells.
Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE
Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]